1995
DOI: 10.1021/ic00113a028
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Structure, and Spectroscopic Properties of Bismuth Citrate Compounds and the Bismuth-Containing Ulcer-Healing Agent Colloidal Bismuth Subcitrate (CBS). 4. Crystal Structure and Solution Behavior of a Unique Dodecanuclear Cluster (NH4)12[Bi12O8(cit)8](H2O)10

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
54
0

Year Published

1996
1996
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(55 citation statements)
references
References 1 publication
1
54
0
Order By: Relevance
“…[44] In contrast, the hexanuclear {Bi 6 } unit A is part of a wide variety of molecular bismuth-oxo clusters. [23,31,32,[41][42][43][44] It has been suggested that in aqueous solution hexanuclear cations of the type [Bi 6 O 4 + x (OH) 4Àx ] (6Àx) + are predominantly found at pH < 3 at low concentrations (0.1 m). With increasing pH, nonanuclear species are formed.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[44] In contrast, the hexanuclear {Bi 6 } unit A is part of a wide variety of molecular bismuth-oxo clusters. [23,31,32,[41][42][43][44] It has been suggested that in aqueous solution hexanuclear cations of the type [Bi 6 O 4 + x (OH) 4Àx ] (6Àx) + are predominantly found at pH < 3 at low concentrations (0.1 m). With increasing pH, nonanuclear species are formed.…”
Section: Discussionmentioning
confidence: 99%
“…The hexanuclear unit A is the most common structural motif reported for bismuth-oxo compounds and is realised in bismuth-oxo(hydroxy) nitrates, [41] bismuth-oxo(hydroxy) perchlorates, [42] bismuth-oxo alkoxides, [23,31,32] and bismuth-oxo carboxylates. [43,44] [Bi 18 (m 3 -O) 12 3 ] in toluene at 4 8C that had been exposed to air moisture. Compounds 7 and 8 both crystallise in the space group P1 with one formula unit per unit cell.…”
mentioning
confidence: 99%
“…Bismuth compounds have been used in medicine for more than 200 years for a variety of gastrointestinal disorders (12,13). There is particular interest in bismuth(III) citrate solubilized by ammonium and potassium hydroxide, which forms the basis of the colloidal bismuth subcitrate present, for example, in the drugs Telen ® (Byk Gulden) and De-Nol ® (Gist Brocade) (14,15). Recently a new adduct of ranitidine with bismuth citrate (Glaxo Wellcome plc), which combines the antisecretory action of ranitidine with mucosal protectant and bactericidal properties of bismuth(III), has been granted a product license in the UK (16,17).…”
mentioning
confidence: 99%
“…Another type of bismuth drug is based on bismuth citrate complexes such as colloidal bismuth subcitrate (CBS, De-Nol; Gist Brocades and Yamanouchi), and ranitidine bismuth citrate (RBC, Tritec and Pylorid, GSK), which is used worldwide to treat various gastrointestinal diseases, caused by the H. pylori infection [15][16][17][18]. Both X-ray analysis and structural modeling suggest that the dimeric units of bismuth citrate ([Bi 2 (cit) 2 ] 2À , Figure 3.2b) may form the negative charged polymeric skeletons in both CBS and RBC, and aggregate to a type of 'hybrid' metal organic framework containing regular meshes with the 'encapsulated' NH 4 þ and K þ (in CBS) or ranitidine (in RBC) [19,20]. Ranitidine bismuth citrate is believed to be more potent in the treatment of gastrointestinal disorders since it combines the activity of ranitidine, which reduces the excretion of gastric acid and bismuth citrate, which protects the mucous membrane of the stomach and inhibits H. pylori colonization.…”
Section: Bismuth In Medicinementioning
confidence: 99%